TERBINAFIN Mepha cpr 250 mg 28 pce

7680571740050 CH-57174 D01BA02 08.06.0.
TERBINAFIN Mepha cpr 250 mg 28 pce
TERBINAFIN Mepha cpr 250 mg 28 pce
TERBINAFIN Mepha cpr 250 mg 28 pce
1 / 3
google

Details

Product number
5717402
CPT
-
Packaging group
28
Unit
Tablette(n)
Composition
terbinafinum 250 mg ut terbinafini hydrochloridum, cellulosum microcristallinum, hypromellosum, carboxymethylamylum natricum A corresp. natrium 1.88 mg, silica colloidalis anhydrica, magnesii stearas, pro compresso.

Articles (1)

Terbinafin-Mepha 250, Tabletten
Tabletten
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
28/03/2022
Patient information leaflet
Français
28/03/2022
Patient information leaflet
Italien
28/03/2022
Professional SmPC
Allemand
28/03/2022
Professional SmPC
Français
28/03/2022
Professional SmPC
Italien
28/03/2022

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.88 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 74.75
Specialties list
Yes
Generic
Yes
SL addition date: 01/08/2005

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
57174
Drug name
Terbinafin-Mepha, Tabletten
Galenic form
TAB
ATC Code
D01BA02
Authorization status
Z
Dispensation category
B
First authorization
15/02/2005
Authorization expiration date
31/12/9999
IT number
08.06.0.
Domain
Human medicine
Field of application
Antimykotikum

Packaging details

Description (FR)
TERBINAFIN Mepha cpr 250 mg 28 pce
Description (DE)
TERBINAFIN Mepha Tabl 250 mg 28 Stk
Market launch
15/02/2005
Narcotic (BTM)
No

Original drug

Lamisil, Tabletten
CHF 39.75
View original

Other packaging sizes

TERBINAFIN Mepha cpr 125 mg 14 pce
14 TABL
View
TERBINAFIN Mepha cpr 250 mg 14 pce
14 TABL
View